false00018139140001813914cmax:WarrantsMember2024-06-102024-06-1000018139142024-06-102024-06-100001813914us-gaap:CommonClassAMember2024-06-102024-06-10

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 10, 2024

 

img232180177_0.jpg 

 

 

CareMax, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-39391

85-0992224

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

1000 NW 57th Court

Suite 400

 

Miami, Florida

 

33126

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 786 360-4768

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common stock, par value $0.0001 per share

 

CMAX

 

The Nasdaq Stock Market LLC

Warrants, each whole warrant exercisable for 1/30th of one share of Class A common stock

 

CMAXW

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective June 10, 2024, the Board of Directors (the “Board”) of CareMax, Inc., a Delaware corporation (the “Company”), appointed Mr. Paul Rundell, a Managing Director at Alvarez & Marsal North America, LLC (“A&M”), as Chief Restructuring Officer (“CRO”) of the Company.

Mr. Rundell, age 49, is a Managing Director in A&M’s restructuring practice, where he focuses on clients in the healthcare industry. Mr. Rundell has been with A&M since 2008. Prior to joining A&M, Mr. Rundell worked with several restructuring and interim management firms. Mr. Rundell has worked with numerous healthcare clients throughout the country, helping them navigate through financial and operational challenges, including serving as Interim Chief Executive Officer of 21st Century Oncology Holdings, Inc. from February 2017 through February 2018. Mr. Rundell is a Certified Insolvency and Restructuring Advisor (CIRA), a Certified Turnaround Professional (CTP) and a member of the Turnaround Management Association (TMA) and the Association of Insolvency and Restructuring Advisors (AIRA). Mr. Rundell holds a Bachelor’s Degree and a Master’s Degree in business administration from the University of Illinois.

Mr. Rundell’s compensation for the CRO position is included as part of the fees paid by the Company to A&M for overall services A&M provides to the Company. There are no additional, and no anticipated additional, compensatory arrangements between the Company and Mr. Rundell in connection with his performance as the Company’s Chief Restructuring Officer beyond such fees paid by the Company to A&M. Other than as disclosed in this Current Report on Form 8-K, there are no arrangements or understandings between Mr. Rundell and any other person pursuant to which Mr. Rundell was appointed to serve as CRO and there are no family relationships between Mr. Rundell and any director or executive officer of the Company. Other than as disclosed in this Current Report on Form 8-K, since the beginning of the Company’s last fiscal year, the Company has not engaged in any transactions, and there are no proposed transactions, or series of similar transactions, in which the Company was or is to be a participant and in which Mr. Rundell had a direct or indirect material interest in which the amount involved exceeds or exceeded $120,000.

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

 

Date:

June 14, 2024

By:

/s/ Kevin Wirges

 

 

 

Name: Kevin Wirges
Title: Executive Vice President, Chief Financial Officer and Treasurer
 

 

v3.24.1.1.u2
Document And Entity Information
Jun. 10, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jun. 10, 2024
Entity Registrant Name CareMax, Inc.
Entity Central Index Key 0001813914
Entity Emerging Growth Company true
Entity File Number 001-39391
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 85-0992224
Entity Address, Address Line One 1000 NW 57th Court
Entity Address, Address Line Two Suite 400
Entity Address, City or Town Miami
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33126
City Area Code 786
Local Phone Number 360-4768
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Common Class A [Member]  
Document Information [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001 per share
Trading Symbol CMAX
Security Exchange Name NASDAQ
Warrants [Member]  
Document Information [Line Items]  
Title of 12(b) Security Warrants, each whole warrant exercisable for 1/30th of one share of Class A common stock
Trading Symbol CMAXW
Security Exchange Name NASDAQ
CareMax (NASDAQ:CMAXW)
Gráfica de Acción Histórica
De May 2024 a Jun 2024 Haga Click aquí para más Gráficas CareMax.
CareMax (NASDAQ:CMAXW)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024 Haga Click aquí para más Gráficas CareMax.